The discrepancies in the prognostic significance of MVD can, in part be explained by considering several factors: tumor heterogeneity, pan-endothelial marker utilised (anti-CD31; anti-CD34; anti-FVIII-RA) and the variability in the choice of hot spots [56]. Here, PECAM1 is linked to neoplasm.